{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:47:55Z","timestamp":1785199675681,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T00:00:00Z","timestamp":1505692800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11910-017-0782-6","type":"journal-article","created":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T04:46:37Z","timestamp":1505709997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["DVT Prevention in Stroke"],"prefix":"10.1007","volume":"17","author":[{"given":"Christopher","family":"Goshgarian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip B.","family":"Gorelick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,18]]},"reference":[{"key":"782_CR1","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/S0140-6736(16)30514-1","volume":"388","author":"M Nisio Di","year":"2016","unstructured":"\u2022\u2022 Di Nisio M, van Es N, Buller HR. Deep venous thrombosis and pulmonary embolism. Lancet. 2016;388:3060\u201373. An excellent review article on the state of the art in relation to venous thromboembolism epidemiology, diagnosis, treatment, and prevention.","journal-title":"Lancet"},{"key":"782_CR2","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(07)60633-3","volume":"369","author":"DG Sherman","year":"2007","unstructured":"Sherman DG, Albers GW, Bladin C, Fieschi C, Gabbai AA, Kase CS, et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischemic stroke (PREVAIL Study): an open-label randomized comparison. Lancet. 2007;369:1347\u201355.","journal-title":"Lancet."},{"key":"782_CR3","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0140-6736(16)31257-0","volume":"388","author":"B Freedman","year":"2016","unstructured":"Freedman B, Potpara TS, Lip GYH. Atrial fibrillation 1. Stroke prevention in atrial fibrillation. Lancet. 2016;388:806\u201317.","journal-title":"Lancet."},{"key":"782_CR4","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jacc.2012.03.019","volume":"60","author":"GYH Lip","year":"2012","unstructured":"Lip GYH, Larsen TB, Skjoth F, Rasmussen LH. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2012;60:738\u201346.","journal-title":"J Am Coll Cardiol."},{"key":"782_CR5","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","volume":"361","author":"S Schulman","year":"2009","unstructured":"Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009;361:2342\u201352.","journal-title":"N Engl J Med."},{"key":"782_CR6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1113697","volume":"368","author":"S Schulman","year":"2013","unstructured":"Schulman S, Kearon C, Kakkar AK, Schellong S, Eriksson H, Baanstra D, et al. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. N Engl J Med. 2013;368:709\u201318.","journal-title":"N Engl J Med."},{"key":"782_CR7","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","volume":"363","author":"EINSTEIN Investigators","year":"2010","unstructured":"Investigators EINSTEIN. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363:2499\u2013510.","journal-title":"N Engl J Med."},{"key":"782_CR8","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","volume":"366","author":"EINSTEIN\u2013PE Investigators","year":"2012","unstructured":"EINSTEIN\u2013PE Investigators. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012;366:1287\u201397.","journal-title":"N Engl J Med."},{"key":"782_CR9","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","volume":"369","author":"H-VTE Investigators","year":"2013","unstructured":"Investigators H-VTE. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med. 2013;369:1406\u201315.","journal-title":"N Engl J Med."},{"key":"782_CR10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","volume":"369","author":"G Agnelli","year":"2013","unstructured":"Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013;369:799\u2013808.","journal-title":"N Engl J Med."},{"key":"782_CR11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","volume":"368","author":"G Agnelli","year":"2013","unstructured":"Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, et al. Apixaban for extended treatment of venous thromboembolism. N Engl J Med. 2013;368:699\u2013708.","journal-title":"N Engl J Med."},{"key":"782_CR12","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","volume":"46","author":"JC Hemphill","year":"2015","unstructured":"Hemphill JC, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. Guidelines for the management of spontaneous intracerebral hemorrhage. A guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2015;46:2032\u201360.","journal-title":"Stroke."},{"key":"782_CR13","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","volume":"44","author":"EC Jauch","year":"2013","unstructured":"Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke. Stroke. 2013;44:870\u2013947.","journal-title":"Stroke."},{"issue":"9988","key":"782_CR14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0140-6736(15)60690-0","volume":"386","author":"AVERT Trial Collaboration Group","year":"2015","unstructured":"AVERT Trial Collaboration Group. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial. Lancet. 2015;386(9988):46\u201355.","journal-title":"Lancet."},{"issue":"2","key":"782_CR15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","volume":"149","author":"C Kearon","year":"2016","unstructured":"\u2022\u2022 Kearon C, Akl EA, Ornelas J, Blalvas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease. CHEST guideline and Expert Panel report. Chest. 2016;149(2):315\u201352. An up-to-date guidance statement on venous thromboembolism prevention and treatment.","journal-title":"Chest"},{"issue":"49","key":"782_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9490","volume":"9","author":"P Roderick","year":"2005","unstructured":"Roderick P, Ferris G, Wilson K, et al. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. Health Technol Assess. 2005;9(49):1\u201378.","journal-title":"Health Technol Assess."},{"key":"782_CR17","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/S0140-6736(09)60941-7","volume":"373","author":"CLOTS Trial Collaboration","year":"2009","unstructured":"CLOTS Trial Collaboration. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicenter, randomised controlled trial. Lancet. 2009;373:1958\u201365.","journal-title":"Lancet."},{"key":"782_CR18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.7326\/0003-4819-153-9-201011020-00280","volume":"153","author":"CLOTS (Clots in Legs Or sTockings after Stroke) Trial Collaboration","year":"2010","unstructured":"CLOTS (Clots in Legs Or sTockings after Stroke) Trial Collaboration. Thigh-length versus below-knee stockings for deep venous thrombosis prophylaxis after stroke: a randomized trial. Ann Intern Med. 2010;153:553\u201362.","journal-title":"Ann Intern Med."},{"key":"782_CR19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.27.5.435","volume":"27","author":"A Turpie","year":"1977","unstructured":"Turpie A, Gallus A, Beattie W, Hirsch J. Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of calf. Neurology. 1977;27:435\u20138.","journal-title":"Neurology."},{"key":"782_CR20","first-page":"24","volume":"260","author":"J Davidson","year":"1993","unstructured":"Davidson J, Williams D, Hoffam M. Effect of intermittent pneumatic compression on intracranial pressure in brain-injured patients. Crit Care Med. 1993;260:24\u20139.","journal-title":"Crit Care Med."},{"key":"782_CR21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1212\/01.wnl.0000176073.80532.a2","volume":"65","author":"K Lacut","year":"2005","unstructured":"Lacut K, Bressollette L, Gal G, Etienne E, Tinteniac A, Renault A, et al. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology. 2005;65:865\u20139.","journal-title":"Neurology."},{"key":"782_CR22","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.50.6.1683","volume":"50","author":"S Kamran","year":"1998","unstructured":"Kamran S, Downey D, Ruff R. Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients. Neurology. 1998;50:1683\u20138.","journal-title":"Neurology."},{"key":"782_CR23","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","volume":"44","author":"EC Jauch","year":"2013","unstructured":"Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2013;44:870\u2013947.","journal-title":"Stroke."},{"issue":"76","key":"782_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19760","volume":"19","author":"CLOTS Trial Collaboration","year":"2015","unstructured":"\u2022\u2022 CLOTS Trial Collaboration. The Clots in Legs Or sTockings after Stroke (CLOTS) 3 trial: a randomised controlled trial to determine whether or not intermittent pneumatic compression reduces the risk of post stroke vein thrombosis and to estimate its cost effectiveness. Health Technol Assess. 2015;19(76):1\u201390. Randomized controlled trial to determine the effectiveness of sequential compression devices in addition to standard care in deep vein thrombosis prevention in acute stroke.","journal-title":"Health Technol Assess"},{"key":"782_CR25","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archinte.164.14.1541","volume":"164","author":"PD Stein","year":"2004","unstructured":"Stein PD, Kayali F, Olson RE. Twenty-one-year trends in the use of inferior vena cava filters. Arch Intern Med. 2004;164:1541\u20135.","journal-title":"Arch Intern Med."},{"key":"782_CR26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jth.13564","volume":"15","author":"L Duffett","year":"2017","unstructured":"Duffett L, Carrier M. Inferior vena cava filters. J Thromb Haemost. 2017;15:2\u201312.","journal-title":"J Thromb Haemost."},{"key":"782_CR27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/1076029613487430","volume":"20","author":"GP Piazza","year":"2014","unstructured":"\u2022 Piazza GP, Goldhaber SZ, Kroll A, Golberg RJ, Emery C, Spencer F. Venous thromboembolism in patients with prior stroke. Clin Appl Thromb Hemost. 2014;20:43\u20139. An analysis of patients with prior stroke and deep vein thrombosis to determine deep vein thrombosis risk factors.","journal-title":"Clin Appl Thromb Hemost"},{"key":"782_CR28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1378\/chest.11-2301","volume":"141","author":"C Kearon","year":"2012","unstructured":"Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinic practice guidelines. Chest. 2012;141:419\u201396.","journal-title":"Chest"},{"key":"782_CR29","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.RVI.0000203418-39769.0D","volume":"17","author":"JA Kaufman","year":"2006","unstructured":"Kaufman JA, Kinney TB, Streiff MB, et al. Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference. J Vasc Interv Radiol. 2006;17:449\u201359.","journal-title":"J Vasc Interv Radiol."},{"key":"782_CR30","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.jvir.2011.08.024","volume":"22","author":"LF Angel","year":"2011","unstructured":"Angel LF, Tapson V, Galgon RE, Restrepo MI, Kaufman J. Systemic review of the use of retrievable inferior vena cava filters. J Vasc Interv Radiol. 2011;22:1522\u201330.","journal-title":"J Vasc Interv Radiol."},{"key":"782_CR31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1586\/erd.12.65","volume":"10","author":"A Dixon","year":"2013","unstructured":"Dixon A, Stavropoulos SW. Improving retrieval rates for retrievable inferior vena cava filters. Expert Rev Med Devices. 2013;10:135\u201341.","journal-title":"Expert Rev Med Devices."},{"key":"782_CR32","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","volume":"349","author":"International Stroke Trial Collaborative Group","year":"1997","unstructured":"International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet. 1997;349:1569\u201381.","journal-title":"Lancet."},{"issue":"1","key":"782_CR33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/jnnp.56.1.17","volume":"56","author":"PA Sandercock","year":"1993","unstructured":"Sandercock PA, Van den Belt AG, Lindely RI, Sattery J. Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomized trials. J Neurol Neurosurg Psychiatry. 1993;56(1):17\u201325.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"782_CR34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/1076029610389026","volume":"17","author":"G Pineo","year":"2011","unstructured":"Pineo G, Lin J, Stern L, Subrahmanian T, Annemans T. Economic impact of enoxaparin after acute ischemic stroke based on PREVAIL. Clin Appl Thromb Hemost. 2011;17:150\u20137.","journal-title":"Clin Appl Thromb Hemost."},{"key":"782_CR35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.thromres.2006.03.010","volume":"119","author":"PW Kamphuisen","year":"2007","unstructured":"Kamphuisen PW, Agnelli G. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Thomb Res. 2007;119:265\u201374.","journal-title":"Thomb Res."}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-017-0782-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-017-0782-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-017-0782-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T03:54:55Z","timestamp":1506052495000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-017-0782-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,18]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["782"],"URL":"https:\/\/doi.org\/10.1007\/s11910-017-0782-6","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,18]]},"article-number":"81"}}